ADTRAN Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated May 27, 2025, concerns ADTRAN Holdings, Inc. (ADTN). The filing addresses the restatement of consolidated financial statements for the fiscal years ended December 31, 2024 and 2023, as well as interim periods ended March 31, June 30, and September 30, 2024. It also covers the unaudited financial results for the quarter ended March 31, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it serves as a notice that updated Non-GAAP financial measures and reconciliations to GAAP measures are contained in attached exhibits (Exhibit 99.1). The filing supersedes preliminary financial information previously released on May 7, 2025.
Material Changes
- Restatement of Financials: The Company restated its financial statements for the 2024 and 2023 fiscal years and specific 2024 interim periods via an Amendment No. 1 to its Form 10-K filed on May 20, 2025.
- Superseding Data: The restated financial statements and the Final Q1 2025 Financials replace the preliminary data included in the May 7, 2025 press release and investor presentation.
Guidance, Outlook, and Management Commentary
Management has provided updated Non-GAAP financial measures and an updated investor presentation reflecting the restated data. The filing does not contain specific forward-looking guidance, risk factors, or commentary on unusual items within the text body; these details are referenced as being included in the attached exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 for the specific updated Non-GAAP financial measures and their reconciliation to GAAP.
- Examine the Amendment No. 1 to the Form 10-K (filed May 20, 2025) to understand the nature and impact of the financial restatement.
- Compare the Final Q1 2025 Financials in the Form 10-Q against the preliminary figures released on May 7, 2025.
- Consult the updated Investor Presentation (Exhibit 99.2) for revised strategic outlooks based on the restated numbers.